-
1دورية أكاديمية
المؤلفون: Puente, Javier, Lainez, Nuria, Dueñas, Marta, Méndez-Vidal, María José, Esteban, Emilio, Castellano, Daniel, Martínez-Fernández, Mónica, Basterretxea, Laura, Juan-Fita, María José, Antón-Aparicio, Luis M., León, Luis, Lambea, Julio, Pérez-Valderrama, Begoña, Vázquez, Sergio, Suárez, Cristina, García del Muro, Xavier, Gallardo, Enrique, Maroto, José Pablo, Samaniego, M. Luz, Suárez-Paniagua, Beatriz, Sanz, Julián, Paramio, Jesús M.
مصطلحات موضوعية: Biomarker, Long-term responders, Metastatic renal cell carcinoma, Primary refractory, Sunitinib
العلاقة: https://doi.org/10.18632/oncotarget.16494Test; Puente J, Laínez N, Dueñas M, Méndez-Vidal MJ, Esteban E, Castellano D, et al. Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma. Oncotarget. 2017;8(18):30410-30421; http://hdl.handle.net/2183/21038Test
-
2دورية أكاديمية
المؤلفون: Liu, Xiaoyan, Swen, Jesse J, Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H J, Rodriguez Antona, Cristina, García-Donas, Jesus, Rini, Brian I, Guchelaar, Henk-Jan
المساهمون: Pfizer, China Scholarship Council
مصطلحات موضوعية: VEGFR1, Meta-analysis, Metastatic renal cell carcinoma, Sunitinib, Validation study, Alleles, Antineoplastic Agents, Carcinoma, Renal Cell, Gene Frequency, Genotype, Humans, Indoles, Kidney Neoplasms, Neoplasm Metastasis, Polymorphism, Single Nucleotide, Prognosis, Proportional Hazards Models, Pyrroles, Treatment Outcome, Vascular Endothelial Growth Factor Receptor-1, Genetic Variation
العلاقة: Publisher's version; https://doi.org/10.18632/oncotarget.13597Test.; Oncotarget. 2017 ;8(1):1204-1212; http://hdl.handle.net/20.500.12105/8486Test; Oncotarget
الإتاحة: https://doi.org/20.500.12105/8486Test
https://doi.org/10.18632/oncotarget.13597Test
https://hdl.handle.net/20.500.12105/8486Test